NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,506,815 | -52.3% | 14,793 | -52.7% | 0.13% | -70.5% |
Q2 2023 | $3,158,382 | +14.3% | 31,299 | +4.2% | 0.45% | +61.7% |
Q1 2023 | $2,763,680 | +84.9% | 30,040 | +82.3% | 0.28% | +14.9% |
Q4 2022 | $1,494,703 | -62.6% | 16,476 | -68.7% | 0.24% | -68.6% |
Q3 2022 | $4,000,000 | +90.7% | 52,631 | +112.1% | 0.77% | +84.2% |
Q2 2022 | $2,097,000 | +86.9% | 24,813 | +93.4% | 0.42% | -4.1% |
Q4 2021 | $1,122,000 | -63.0% | 12,831 | -65.4% | 0.44% | -43.1% |
Q3 2021 | $3,032,000 | -99.8% | 37,079 | +87.7% | 0.76% | +128.4% |
Q2 2021 | $1,802,000,000 | +446.1% | 19,753 | +411.1% | 0.34% | +210.2% |
Q1 2021 | $330,000,000 | +118.5% | 3,865 | +122.9% | 0.11% | +9.1% |
Q3 2020 | $151,000,000 | +48.0% | 1,734 | +48.7% | 0.10% | +182.9% |
Q2 2020 | $102,000,000 | -71.4% | 1,166 | -73.0% | 0.04% | -54.5% |
Q1 2020 | $357,000,000 | -86.1% | 4,326 | -84.1% | 0.08% | -70.3% |
Q4 2019 | $2,572,000,000 | – | 27,158 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |